series-b
Stage
3
Investors
About
Elpiscience develops innovative immunotherapy treatments addressing unmet clinical needs in oncology and autoimmune diseases through proprietary antibody discovery and clinical development.
Explore Elpiscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.